Literature DB >> 22333704

Procalcitonin to detect invasive bacterial infection in non-toxic-appearing infants with fever without apparent source in the emergency department.

Carlos Luaces-Cubells1, Santiago Mintegi, Juan-José García-García, Eider Astobiza, Roser Garrido-Romero, Jesús Velasco-Rodríguez, Javier Benito.   

Abstract

The reliability of procalcitonin as a predictor of invasive infection in infants <36 months of age with fever and nontoxic appearance was assessed in 868 patients, 15 (1.7%) of whom had invasive infection. The area under the receiver operating characteristic curve for procalcitonin was 0.87 (optimum cutoff 0.9 ng/mL, sensitivity 86.7%, specificity 90.5%), whereas for C-reactive protein it was 0.79 (optimum cutoff 91 mg/L, sensitivity 33.3%, specificity 95.9%). In infants with fever of <8 hours duration, the area under the receiver operating characteristic curve was 0.97 for procalcitonin and 0.76 for C-reactive protein. Procalcitonin was a useful biomarker to predict invasive infection in non-toxic-appearing infants with fever without apparent focus, particularly in febrile episodes of <8 hours duration.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22333704     DOI: 10.1097/INF.0b013e31824dacf4

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  7 in total

1.  Lack of value of midregional pro-adrenomedullin and C-terminal pro-endothelin-1 for prediction of severe bacterial infections in infants with fever without a source.

Authors:  Javier Benito; Carlos Luaces-Cubells; Santiago Mintegi; Eider Astobiza; Lorea Martinez-Indart; Ana Valls-Lafont; Juan-José García-García
Journal:  Eur J Pediatr       Date:  2013-06-22       Impact factor: 3.183

2.  Evaluation of the bedside Quikread go® CRP test in the management of febrile infants at the emergency department.

Authors:  S Hernández-Bou; V Trenchs; M I Vanegas; A F Valls; C Luaces
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-02-03       Impact factor: 3.267

3.  Validation of the Feverkidstool and procalcitonin for detecting serious bacterial infections in febrile children.

Authors:  Ruud G Nijman; Yvonne Vergouwe; Henriëtte A Moll; Frank J Smit; Floor Weerkamp; Ewout W Steyerberg; Johan van der Lei; Yolanda B de Rijke; Rianne Oostenbrink
Journal:  Pediatr Res       Date:  2017-11-08       Impact factor: 3.756

4.  Use of procalcitonin and C-reactive protein in the diagnosis of bacterial infection in infants with severe bronchiolitis.

Authors:  Carme Alejandre; Carmina Guitart; Mònica Balaguer; Isabel Torrús; Sara Bobillo-Perez; Francisco José Cambra; Iolanda Jordan
Journal:  Eur J Pediatr       Date:  2020-09-14       Impact factor: 3.183

5.  Role of procalcitonin in diagnosis of community acquired pneumonia in Children.

Authors:  Vinod H Ratageri; Puspha Panigatti; Aparna Mukherjee; Rashmi R Das; Jagdish Prasad Goyal; Javeed Iqbal Bhat; Bhadresh Vyas; Rakesh Lodha; Deepak Singhal; Prawin Kumar; Kuldeep Singh; Samarendra Mahapatro; Bashir Ahmad Charoo; S K Kabra; K R Jat
Journal:  BMC Pediatr       Date:  2022-04-20       Impact factor: 2.567

Review 6.  Is Procalcitonin Useful in Pediatric Critical Care Patients?

Authors:  Sara Bobillo-Perez; Javier Rodríguez-Fanjul; Iolanda Jordan Garcia
Journal:  Biomark Insights       Date:  2018-08-07

Review 7.  Fever in Children: Pearls and Pitfalls.

Authors:  Egidio Barbi; Pierluigi Marzuillo; Elena Neri; Samuele Naviglio; Baruch S Krauss
Journal:  Children (Basel)       Date:  2017-09-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.